ロード中...
An Analysis of Recent FDA Oncology Scientific Publications
In addition to its primary regulatory role, the Office of Hematology and Oncology Products at the U.S. Food and Drug Administration (FDA) is engaged in many forms of scientific authorship. During the period of 2010 to 2018, FDA oncology staff contributed to 356 publications in the scientific literat...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066718/ https://ncbi.nlm.nih.gov/pubmed/32162806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0503 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|